Led · Equity · Apr 2023

Maltego provides an intelligence platform that integrates data and offers graphical link analysis for investigations. The platform centralizes data in a single interface and uses visualization and collaborative capabilities to help investigators zero in on relevant information. Its users include security professionals, penetration testers, forensic investigators, investigative journalists, and market researchers. Maltego is led by CEO Philip Mayrhofer and is headquartered in Munich, Germany, with over 100 employees in Germany. Customers cited in the article include the Federal Bureau of Investigation, INTERPOL, and roughly half of the Dow 30. Financially, the company received a $100M growth investment from Charlesbank Technology Opportunities Funds in April 2023.

Led · Series A · Mar 2022

Palladius Capital Management is a tactically contrarian real estate investment manager that leverages institutional best practices, technology and operational expertise to drive value for institutional and individual investors. The firm pursues value-add and core-plus strategies through affiliates, targeting multifamily, student housing, hospitality and other thematic investments. Leadership includes CEO Nitin Chexal and Senior Managing Directors Manish Shah, Marko Velazquez and Jaime Hinojosa. Since its inception in July 2021 the company and its affiliates have acquired approximately $500 million in assets. The company intends to use new funding to accelerate growth, expand operations and broaden its business reach.

Led · Equity · Feb 2022

Solve Advisors delivers pre-trade price transparency and market pricing via its SolveQuotes platform. SolveQuotes uses proprietary natural language processing and machine learning to parse clients' unstructured messages and aggregate millions of daily bids, offers and market color across securitized products, corporate bonds, syndicated bank loans, credit default swaps and municipal bonds. The platform and data feeds, combined with proprietary analytics, produce real-time market consensus pricing, facilitate BWIC monitoring, identify trading opportunities, and visualize pricing and liquidity trends. Founded in 2011 and led by co-founders Eugene Grinberg and Gerard Nealon, Solve operates across the US, UK, India, the Caribbean and APAC. The company plans to use new capital to accelerate product innovation, expand its data aggregation and analytics capabilities, pursue strategic acquisitions, and grow go-to-market and operations globally. Charlesbank's investment of over $80 million follows prior funding from Credit Suisse Asset Management's NEXT Investors in August 2019, with NEXT remaining an investor.

Participated · Equity · Mar 2021

Eat Just develops plant-based egg alternatives (JUST Egg) and operates a cultivated meat business (GOOD Meat). JUST Egg is made with mung bean protein and is the company’s core consumer product, with a 51% repeat purchase rate and distribution in 48,000+ North American retail points plus ~10,000 additional branded partnership points. Foodservice sales grew 15% and 39% in Q1 and Q2 respectively, and foodservice is now gross-margin-positive, while the company has said JUST Egg is “closer to operational profitability.” The company has taken cost and headcount actions (an 18% layoff earlier this year) and is focused on improving margins through more efficient mung bean sourcing, increased scale, monetizing co-products (mung bean starch), and better protein extraction. GOOD Meat currently sells limited amounts in the U.S. and Singapore but will need to raise significant capital to fund a large-scale U.S. plant. Eat Just was launched in December 2011 and has previously raised roughly $850 million in total financing, including about $270 million for GOOD Meat. Eat Just, founded in 2011 and formerly known as Hampton Creek, makes mung bean–based plant eggs and is advancing cultivated meat made from animal cells grown in a lab. Its plant-based eggs are already sold on Alibaba’s e-commerce platform in China, where it has operated for three years. The company plans to file with Chinese regulators for its cultivated meat "sometime this year" and previously obtained permission to sell lab-grown meat in Singapore in late 2020. Eat Just has raised over $400 million from investors including Khosla Ventures and Li Ka-shing’s Horizon Ventures. China currently accounts for about 5% of Eat Just’s global sales, and the company sees local production as a priority to cut logistics costs and compete on price with conventional eggs and meat. It faces competition from both local alternative-protein startups and lower-cost traditional animal products, and is focusing on consumer education and taste-driven innovation. Eat Just, launched in 2011 as Hampton Creek, develops plant-based egg replacements and lab-grown poultry under its GOOD Meat line. The company’s product set includes plant-based egg replacement products and eggless mayonnaise alongside its lab-grown chicken offerings, and it is described as the first government-approved vendor of lab-grown chicken. Eat Just sells products in more than 20,000 retail outlets and 1,000 foodservice locations, has moved over 100 million eggs to roughly one million U.S. households, and has distribution deals including Dicos in China and placements at Peet’s Coffee; it has expanded eggless distribution into Canada. GOOD Meat was available for a short time in Singapore, and the company says it expects to slash production costs and expand commercial operations while working on other kinds of meats. The company went through governance turmoil in 2017, including a failed coup, executive firings and a full board resignation that was later replaced. Eat Just has raised capital to build out capacity for its egg replacement products and its lab-grown meat business. Hampton Creek develops plant-based food products using novel ingredients and food‑science techniques; its newest product, Just Scramble, is a mung-bean scramble that tastes like egg and is free of antibiotics and cholesterol. The company launched Just Scramble first in San Francisco with plans to expand to additional locations and cities in 2018 and said the new capital will be used to scale the product. Hampton Creek reported having grown from zero to 100,000 points of distribution over four years and described several of its SKUs as among the fastest-selling in multiple categories. The company received FDA confirmation of GRAS status for its mung bean protein isolate prior to the launch. Hampton Creek published sustainability metrics showing Just-branded products save fresh water and reduce greenhouse-gas emissions versus conventional egg-based products; those metrics were independently validated by Third Partners. Management said it is reviewing additional sustainability factors such as soil health, fossil fuel use, and fertilizer run-off to broaden its environmental analysis. Hampton Creek makes plant‑based food products (notably Just Mayo and Just Cookies) using ingredients like yellow pea protein and is rapidly expanding retail and food‑service distribution. Its products now appear in major U.S. retailers including Whole Foods, Costco, Walmart, Target, Kroger and food‑service Compass Group, and it has expanded internationally into Hong Kong’s PARKnSHOP. The company plans to scale R&D with lab automation, a robotic lab and a project to build the world’s largest database of plants to accelerate ingredient discovery. Hampton Creek is developing additional products including scrambled eggs, pasta, healthier sugar substitutes and improved oils, and says some new capital will accelerate expansion in Western Europe and Asia. The startup has grown quickly and is adding office space to relieve crowded conditions among employees. Founder Josh Tetrick has signaled aggressive long‑term ambitions to become a global household food brand. The company has attracted major backers including Bill Gates (indirectly via Khosla) and Li Ka‑Shing and is navigating a public legal dispute with Unilever over the right to use the word “Mayo.”

Led · Equity · Jan 2021

Healthcare Fraud Shield offers the FWAShield™ suite, a next-generation SaaS platform that uses proprietary data, artificial intelligence, rules and algorithms to identify fraud, waste and abuse for healthcare payers. The platform covers both pre-payment and post-payment workflows and combines medical and pharmacy claims, and includes workflow and productivity tools to boost investigator efficiency. Its AI models and analytics are continuously updated by an internal team of FWA experts. Customers who have implemented the FWAShield suite have realized millions of dollars in savings and reported high ROI. The company plans to accelerate investment in proprietary analytics, artificial intelligence, new products (including AIShield™ and PreShield™) and customer service to expand deployments across insurance plans covering millions of lives. Leadership continuity is intact with Mike Moseler (President & CTO), Tony Rademeyer (EVP Sales) and Karen Weintraub (EVP SIU) continuing to lead the business.